Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

A 46-year-old woman, G1P1, presents to the clinic with a 4-week history of heavy, erratic vaginal bleeding. Her previous menstrual cycles were unpredictable, occurring every 2 to 6 months. She has a history of type 2 diabetes mellitus and obesity. She also notes severe fatigue and cold intolerance over the past several months. Her BMI is 42 kg/m242 \text{ kg/m}^2. Vital signs show a blood pressure of 135/85 mm Hg135/85 \text{ mm Hg} and a heart rate of 62/min62/\text{min}. Pelvic examination reveals a normal-appearing cervix with dark blood in the vaginal vault, and no palpable adnexal masses. A urine beta-hCG test is negative.

Initial laboratory studies show:
Hemoglobin: 9.8 g/dL9.8 \text{ g/dL}
Thyroid-stimulating hormone (TSH): 0.8 mU/L0.8 \text{ mU/L} (Normal: 0.5−5.0 mU/L0.5-5.0 \text{ mU/L})
Free thyroxine (T4): 0.5 ng/dL0.5 \text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL})

Which of the following is the most appropriate next step in management?

  1. Endometrial biopsyCevap
  2. B
    Transvaginal ultrasonography
  3. C
    Initiation of levothyroxine therapy
  4. D
    Placement of a levonorgestrel-releasing intrauterine device
  5. E
    Measurement of serum testosterone and dehydroepiandrosterone sulfate

Cevap

The most appropriate next step in management is an endometrial biopsy.
The most appropriate initial step in managing this patient is an endometrial biopsy. She is 46 years old and presents with abnormal uterine bleeding (AUB). According to current clinical guidelines, all women aged 45 years and older with AUB must undergo endometrial sampling to rule out endometrial hyperplasia or carcinoma. Her extreme obesity (BMI 42 kg/m242 \text{ kg/m}^2) and history of chronic oligomenorrhea are significant independent risk factors, as they result in prolonged exposure to unopposed estrogen. While her thyroid studies indicate a secondary endocrine issue, ruling out a gynecologic malignancy takes immediate precedence.

Adım Adım Çözüm

1
Evaluate the patient's age and bleeding pattern.
The patient is 46 years old and presenting with heavy, erratic abnormal uterine bleeding (AUB).
Age is the most critical risk factor for endometrial cancer. Guidelines mandate tissue diagnosis for AUB in patients aged 45 and older.
2
Assess additional risk factors for endometrial malignancy.
The patient has a BMI of 42 kg/m² and a history of chronic oligomenorrhea.
Obesity causes peripheral conversion of androgens to estrogens, and chronic anovulation results in a lack of progesterone. This leads to prolonged unopposed estrogen exposure, exponentially increasing the risk of endometrial hyperplasia and cancer.
3
Analyze the endocrine laboratory findings.
TSH is inappropriately normal (0.8 mU/L) in the setting of a low Free T4 (0.5 ng/dL).
This pattern indicates central hypothyroidism. While this requires eventual pituitary evaluation (e.g., MRI, cortisol check), the immediate life-threatening risk is endometrial cancer, making biopsy the priority.
4
Determine the definitive next step.
Endometrial biopsy must be performed.
It is the standard-of-care initial step to obtain a tissue diagnosis before any medical management is initiated or other non-urgent endocrine workups are pursued.

Anahtar Kavram

Women aged 45 years and older presenting with abnormal uterine bleeding (AUB) require an endometrial biopsy as the initial step in management to rule out endometrial hyperplasia and cancer.
Tahmini Süre:1m 15s
Bu soruyu puanla